DaVita HealthCare Partners Inc.
http://www.davita.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From DaVita HealthCare Partners Inc.
Will Epoetin Biosimilar Serve As Non-Medical Switching Case Study?
Analysts expect potential broad uptake of biosimilars in chronic kidney disease treated at dialysis centers, which could lead to patients being switched off Amgen's Epogen.
Will Epoetin Biosimilar Serve As Non-Medical Switching Case Study?
Analysts expect potential broad uptake of biosimilars in chronic kidney disease treated at dialysis centers, which could lead to patients being switched off Amgen's Epogen.
Amgen’s Repatha Passes CVOT Test, But Contribution To 2017 Sales Growth Unclear
Amgen’s PCSK9 inhibitor Repatha succeeded in the FOURIER cardiovascular outcomes study, but the data may not impact the company’s revenue until 2018 – after a potential revenue decline in 2017.
Medtronic Expands Renal Disease Focus With Bellco Buy
Medtronic has bought Bellco Health, adding the Italian company's hemodialysis products to its recently-formed Renal Care Solutions division.
Company Information
- Industry
- Medical Devices
- Services